Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
暂无分享,去创建一个
M. Pittelkow | L. Shultz | S. Grando | V. Nguyen | A. Ndoye
[1] J. Stanley. Defective cell-cell adhesion in the epidermis. , 1995, Ciba Foundation symposium.
[2] Komai,et al. Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus , 1999, The British journal of dermatology.
[3] M. Seishima,et al. Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell datachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C. , 1999, The journal of investigative dermatology. Symposium proceedings.
[4] J. Schiltz,et al. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. , 1976, The Journal of investigative dermatology.
[5] Elaine Fuchs,et al. Directed Actin Polymerization Is the Driving Force for Epithelial Cell–Cell Adhesion , 2000, Cell.
[6] J. Stanley. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. , 1993, Advances in immunology.
[7] M. A. Robledo,et al. The calcium-sensitive epitope of pemphigus foliaceus antigen is present on a murine tryptic fragment and constitutes a major antigenic region for human autoantibodies. , 1991, The Journal of investigative dermatology.
[8] J. Uitto,et al. Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris , 1997, The Journal of cell biology.
[9] M. S. Steinberg,et al. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. , 1986, Journal of immunology.
[10] E. Beutner,et al. Demonstration of Skin Antibodies in Sera of Pemphigus Vulgaris Patients by Indirect Immunofluorescent Staining.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[11] E. Beutner,et al. Immunofluorescence Tests , 1985, International journal of dermatology.
[12] S. Grando,et al. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. , 2000, The American journal of pathology.
[13] T. Nishikawa,et al. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1. , 1995, Epithelial cell biology.
[14] K. Cehrs,et al. Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes , 1993, The Journal of cell biology.
[15] T. Mauro,et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease , 2000, Nature Genetics.
[16] M. Udey,et al. Pemphigus--diseases of antidesmosomal autoimmunity. , 1999, JAMA.
[17] L. Diaz,et al. Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. , 1995, The Journal of investigative dermatology.
[18] T. Nishikawa,et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. , 1998, The Journal of clinical investigation.
[19] X Ding,et al. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. , 1997, The Journal of investigative dermatology.
[20] J. Sundberg,et al. Vesicle formation and follicular root sheath separation in mice homozygous for deleterious alleles at the balding (bal) locus. , 1997, The Journal of investigative dermatology.
[21] D. Swanson,et al. Methylprednisolone inhibits pemphigus acantholysis in skin cultures. , 1983, The Journal of investigative dermatology.
[22] M. Amagai. Adhesion molecules. I: Keratinocyte-keratinocyte interactions; cadherins and pemphigus. , 1995, The Journal of investigative dermatology.
[23] T. Nishikawa,et al. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. , 1999, Journal of the American Academy of Dermatology.
[24] Zhi Hong Wang,et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. , 1999, The Journal of clinical investigation.
[25] J. Stanley. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. , 1989, The Journal of clinical investigation.
[26] R. F. Johnston,et al. Autoradiography using storage phosphor technology , 1990, Electrophoresis.
[27] S. Grando. Biological functions of keratinocyte cholinergic receptors. , 1997, The journal of investigative dermatology. Symposium proceedings.
[28] T. Nishikawa,et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. , 1997, Journal of immunology.
[29] P. Lenz,et al. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. , 1999, Archives of dermatology.
[30] D. Kelsell,et al. N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. , 1999, Human molecular genetics.
[31] M. Mahoney,et al. Explanation for localization of blisters in pemphigus patients , 1998 .
[32] M. Yaar,et al. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. , 1982, The Journal of clinical investigation.
[33] G. Lazarus,et al. Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Amagai,et al. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. , 1992, The Journal of clinical investigation.
[35] T. Nishikawa,et al. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. , 1994, The Journal of clinical investigation.
[36] J. Caulfield,et al. An electron microscopic study of acantholysis in pemphigus vulgaris. , 1961, The Journal of investigative dermatology.
[37] Masayuki Amagai,et al. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion , 1991, Cell.
[38] E. Fuchs,et al. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation , 1996, The Journal of cell biology.
[39] S. Grando,et al. Pemphigus Vulgaris Antibody Identifies Pemphaxin , 2000, The Journal of Biological Chemistry.
[40] S. Grando. Autoimmunity to Keratinocyte Acetylcholine Receptors in Pemphigus , 2000, Dermatology.
[41] T. Nishikawa,et al. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. , 1990, The Journal of investigative dermatology.
[42] C. Thivolet,et al. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. , 1984, The Journal of clinical investigation.
[43] S. Grando,et al. Activation of keratinocyte muscarinic acetylcholine receptors reverses pemphigus acantholysis , 1993 .
[44] Y. Takahashi,et al. Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. , 1984, The Journal of investigative dermatology.
[45] M. Mahoney,et al. Postnatal lethality of P-cadherin/desmoglein 3 double knockout mice: demonstration of a cooperative effect of these cell adhesion molecules in tissue homeostasis of stratified squamous epithelia. , 2000, The Journal of investigative dermatology.
[46] L. Diaz,et al. Pemphigus foliaceus sera recognize an N-terminal fragment of bovine desmoglein 1. , 1994, The Journal of investigative dermatology.
[47] J. Benz,et al. Annexins: from structure to function. , 1997, Biological chemistry.
[48] T. Nishikawa,et al. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. , 1996, The Journal of investigative dermatology.
[49] T. X. Lee,et al. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. , 1998, Archives of dermatology.
[50] J. Zone,et al. Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. , 1993, The Journal of investigative dermatology.
[51] J. Voorhees,et al. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. , 1982, The New England journal of medicine.
[52] J. Stanley,et al. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. , 1988, The Journal of clinical investigation.
[53] Y. Aoyama,et al. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. , 1999, The Journal of investigative dermatology.
[54] N. Craddock,et al. Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease , 1999, Nature Genetics.
[55] Y. Aoyama,et al. A pathogenic autoantibody, pemphigus vulgaris‐IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes , 1999, European journal of immunology.
[56] T. Nishikawa,et al. Immunoblot assay as an aid to the diagnoses of unclassified cases of pemphigus. , 1991, Archives of dermatology.
[57] C. Zouboulis,et al. Storage phosphor imaging technique improves the accuracy of RNA quantitation using 32P-labeled cDNA probes. , 1994, BioTechniques.
[58] N. Korman,et al. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. , 1989, The New England journal of medicine.
[59] T. Nishikawa,et al. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. , 1995, The Journal of investigative dermatology.
[60] W. Xue. American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. Pemphigus vulgaris IgG regulates expression of urokinase receptor and junctional proteins that may contribute to acantholysis. , 1999, Journal of the American Academy of Dermatology.
[61] L. Diaz,et al. The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. , 1999, The Journal of investigative dermatology.